|
PRPF18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.116300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.221100E-03 |
| Normal-vs-Stage2 |
6.809500E-04 |
| Normal-vs-Stage3 |
1.764300E-02 |
| Normal-vs-Stage4 |
3.538700E-03 |
| Stage1-vs-Stage2 |
2.311400E-01 |
| Stage1-vs-Stage3 |
5.828600E-01 |
| Stage1-vs-Stage4 |
4.061200E-01 |
| Stage2-vs-Stage3 |
7.315200E-01 |
| Stage2-vs-Stage4 |
8.096600E-01 |
| Stage3-vs-Stage4 |
6.847000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.396800E-03 |
| Normal-vs-AfricanAmerican |
3.446600E-01 |
| Normal-vs-Asian |
9.089200E-01 |
| Caucasian-vs-AfricanAmerican |
6.798400E-01 |
| Caucasian-vs-Asian |
3.894600E-01 |
| AfricanAmerican-vs-Asian |
8.003200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.024280E-02 |
| Normal-vs-Female |
6.693600E-02 |
| Male-vs-Female |
5.263600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.192600E-04 |
| Normal-vs-Extreme_Weight |
1.278510E-03 |
| Normal-vs-Obese |
8.015100E-03 |
| Normal-vs-Extreme_Obese |
1.995190E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.906400E-01 |
| Normal_Weight-vs-Obese |
1.439650E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.257800E-01 |
| Extreme_Weight-vs-Obese |
6.089600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.475600E-01 |
| Obese-vs-Extreme_Obese |
6.584000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.329800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.579560E-01 |
| Normal-vs-Age(61-80Yrs) |
2.018400E-03 |
| Normal-vs-Age(81-100Yrs) |
3.375100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.431200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.357200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.029600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.584800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.445560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.030400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.231000E-01 |
| Normal-VS-Type2 PRCC |
2.028100E-04 |
| Normal-VS-KIRP CIMP |
3.040400E-02 |
| Normal-VS-Unclassified PRCC |
2.028300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.422430E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.315600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.812550E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.246000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.106200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.465000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.368400E-04 |
| Normal-vs-N1 |
8.012200E-01 |
| Normal-vs-N2 |
1.716410E-03 |
| N0-vs-N1 |
2.342600E-01 |
| N0-vs-N2 |
2.337600E-01 |
| N1-vs-N2 |
4.210800E-01 |
|
|
